Stock-Based Compensation: The estimated market value of stock options, warrants and other stock-based compensation given to employees and/or vendors.
Hikma Pharmaceuticals Plc (HKMPF) Stock-Based Compensation data is not available for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
| Balance Sheet Financials | |
$2.64B |
|
$2.58B |
|
$4.16B |
|
$5.67B |
|
$1.45B |
|
$1.49B |
|
$1.61B |
|
$3.06B |
|
$2.61B |
|
$1.44B |
|
$2.61B |
|
-- |
|
| Cash Flow Statement Financials | |
$436.00M |
|
$-388.00M |
|
$-25.00M |
|
$188.00M |
|
$217.00M |
|
$29.00M |
|
|
Stock-Based Compensation |
-- |
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|